{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T17:40:11Z","timestamp":1727545211660},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["No.7224324"],"award-info":[{"award-number":["No.7224324"]}]},{"name":"\u201cYoung talents\u201d program of Beijing hospitals Authority","award":["QML20231606"],"award-info":[{"award-number":["QML20231606"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-024-00746-8","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T17:01:51Z","timestamp":1727542911000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the possible role of MmpL7 efflux pump in SQ109 resistance in Mycobacterium tuberculosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Wei","family":"Jing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naihui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"746_CR1","unstructured":"World Health Organization. Global tuberculosis report 2023: Geneva: World Health Organization 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240083851"},{"key":"746_CR2","unstructured":"WHO. World Health Organization WHO Announces Updated Definitions of Extensively Drug-Resistant Tuberculosis. 2021. https:\/\/www.who.int\/news\/item\/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis"},{"key":"746_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40001-021-00502-0","volume":"26","author":"MW Zhang","year":"2021","unstructured":"Zhang MW, Zhou L, Zhang Y, et al. Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China. Eur J Med Res. 2021;26:31.","journal-title":"Eur J Med Res"},{"key":"746_CR4","doi-asserted-by":"publisher","first-page":"100285","DOI":"10.1016\/j.jctube.2021.100285","volume":"25","author":"TA Black","year":"2021","unstructured":"Black TA, Buchwald UK. The pipeline of new molecules and regimens against drug-resistant tuberculosis. J Clin Tuberc Other Mycobact Dis. 2021;25:100285.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"Suppl 1","key":"746_CR5","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","volume":"130","author":"E Vanino","year":"2023","unstructured":"Vanino E, Granozzi B, Akkerman OW, et al. Update of drug-resistant tuberculosis treatment guidelines: a turning point. Int J Infect Dis. 2023;130(Suppl 1):S12\u20135.","journal-title":"Int J Infect Dis"},{"key":"746_CR6","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.05708-11","volume":"56","author":"K Tahlan","year":"2012","unstructured":"Tahlan K, Wilson R, Kastrinsky DB, et al. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2012;56:1797\u2013809.","journal-title":"Antimicrob Agents Chemother"},{"key":"746_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/jac\/dkl227","volume":"58","author":"P Chen","year":"2006","unstructured":"Chen P, Gearhart J, Protopopova M, et al. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro. J Antimicrob Chemother. 2006;58:332\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"746_CR8","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1128\/AAC.01601-09","volume":"54","author":"VM Reddy","year":"2010","unstructured":"Reddy VM, Einck L, Andries K, Nacy CA. Interactions between New Antitubercular drug candidates SQ109 and TMC207. Antimicrob Agents Ch. 2010;54:2840\u20136.","journal-title":"Antimicrob Agents Ch"},{"key":"746_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijantimicag.2015.01.012","volume":"45","author":"ZJ Zhang","year":"2015","unstructured":"Zhang ZJ, Pang Y, Wang YF, et al. Differences in risk factors and drug susceptibility between and lung diseases in China. Int J Antimicrob Ag. 2015;45:491\u20135.","journal-title":"Int J Antimicrob Ag"},{"key":"746_CR10","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1128\/JCM.00244-07","volume":"45","author":"B van Klingeren","year":"2007","unstructured":"van Klingeren B, Dessens-Kroon M, van der Laan T, et al. Drug susceptibility testing of complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol. 2007;45:2662\u20138.","journal-title":"J Clin Microbiol"},{"key":"746_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2147\/IDR.S240716","volume":"13","author":"FZ Zhang","year":"2020","unstructured":"Zhang FZ, Li SS, Wen SA, et al. Comparison of in vitro susceptibility of Mycobacteria against PA-824 to identify key residues of Ddn, the Deazoflavin-Dependent Nitroreductase from. Infect Drug Resist. 2020;13:815\u201322.","journal-title":"Infect Drug Resist"},{"key":"746_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.mimet.2011.05.016","volume":"86","author":"Y Pang","year":"2011","unstructured":"Pang Y, Zhou Y, Wang SF, et al. A novel method based on high resolution melting (HRM) analysis for MIRU-VNTR genotyping of. J Microbiol Meth. 2011;86:291\u20137.","journal-title":"J Microbiol Meth"},{"key":"746_CR13","doi-asserted-by":"crossref","unstructured":"Franz\u00e9n O, Arner E, Ferella M et al. The short non-coding transcriptome of the Protozoan parasite. Plos Negl Trop D 2011;5.","DOI":"10.1371\/journal.pntd.0001283"},{"issue":"4","key":"746_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"746_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1021\/cc020071p","volume":"5","author":"RE Lee","year":"2003","unstructured":"Lee RE, Protopopova M, Crooks E, et al. Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates. J Comb Chem. 2003;5:172\u201387.","journal-title":"J Comb Chem"},{"key":"746_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/jac\/dki319","volume":"56","author":"M Protopopova","year":"2005","unstructured":"Protopopova M, Hanrahan C, Nikonenko B, et al. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. J Antimicrob Chemoth. 2005;56:968\u201374.","journal-title":"J Antimicrob Chemoth"},{"key":"746_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2217\/fmb.12.56","volume":"7","author":"KA Sacksteder","year":"2012","unstructured":"Sacksteder KA, Protopopova M, Barry CE, et al. Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. Future Microbiol. 2012;7:823\u201337.","journal-title":"Future Microbiol"},{"issue":"11","key":"746_CR18","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/biomedicines10112793","volume":"10","author":"M Imran","year":"2022","unstructured":"Imran M, Arora MK, Chaudhary A, et al. MmpL3 inhibition as a Promising Approach to develop Novel therapies against Tuberculosis: a spotlight on SQ109, Clinical studies, and patents Literature. Biomedicines. 2022;10(11):2793.","journal-title":"Biomedicines"},{"key":"746_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.bjp.0705984","volume":"144","author":"J Jia","year":"2005","unstructured":"Jia J, Tomaszewski JE, Hanrahan C, et al. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. Brit J Pharmacol. 2005;144:80\u20137.","journal-title":"Brit J Pharmacol"},{"key":"746_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21292\/2075-1230-2018-96-3-6-18","volume":"96","author":"S Borisov","year":"2018","unstructured":"Borisov S, Bogorodskaya E, Volchenkov G, et al. Efficiency and safety of chemotherapy regimen with SQ109 in those suffering from multiple drug resistant tuberculosis. Tuberculosis lung Dis. 2018;96:6\u201318.","journal-title":"Tuberculosis lung Dis"},{"key":"746_CR21","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1042\/BST20190950","volume":"48","author":"JR Bolla","year":"2020","unstructured":"Bolla JR. Targeting MmpL3 for anti-tuberculosis drug development. Biochem Soc Trans. 2020;48:1463\u201372.","journal-title":"Biochem Soc Trans"},{"key":"746_CR22","doi-asserted-by":"publisher","first-page":"e0153222","DOI":"10.1128\/aac.01532-22","volume":"67","author":"J Xu","year":"2023","unstructured":"Xu J, Li D, Shi J, et al. Bedquiline Resistance mutations: correlations with drug exposures and impact on the Proteome in M. Tuberculosis. Antimicrob Agents Chemother. 2023;67:e0153222.","journal-title":"Antimicrob Agents Chemother"},{"key":"746_CR23","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1128\/AAC.49.11.4775-4777.2005","volume":"49","author":"MR Pasca","year":"2005","unstructured":"Pasca MR, Guglierame P, De Rossi E, et al. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob Agents Ch. 2005;49:4775\u20137.","journal-title":"Antimicrob Agents Ch"},{"key":"746_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1074\/jbc.M100662200","volume":"276","author":"LRCP Camacho","year":"2001","unstructured":"Camacho LRCP, Raynaud C, Laneelle MA, et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J Biol Chem. 2001;276:9.","journal-title":"J Biol Chem"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00746-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-024-00746-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00746-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T17:02:41Z","timestamp":1727542961000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-024-00746-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1186\/s12941-024-00746-8","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participants"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}